On the basis of government appointment technicalities and religious freedom, Americans may lose free coverage for cancer and blood pressure screenings, HIV prevention medication and other essential services.
Articles on Health insurance
Displaying 61 - 80 of 172 articles
The program’s expenses are rising rapidly as baby boomers retire and health care costs grow.
Trauma insurance provides a benefit for life-threatening medical conditions that seriously compromise the insured person’s current and future quality of life.
Evidence from Massachusetts suggests that a multistep process discourages enrollment. The findings could help policymakers stave off a sharp decline in coverage when COVID-19 policies change.
From primary care to cancer screening and insurance coverage, gender-diverse people still face many hurdles to getting good medical care.
Caught up in the latest Medibank cybersecurity breach? Not happy with your premiums? Here’s what you need to know about switching health insurer.
This rare procedure is offered by only a handful of centers in the US and around the world and should be used only when less invasive treatment options for OCD have been tried.
Pandemic-related policies made it easier for states to afford to cover more people and made that coverage more stable for millions of Americans who rely on the program for health care.
Judge Reed O'Connor ruled in a case that coverage for HIV prevention medicine PrEP violated the religious freedom of the plaintiffs. It is unclear whether the order will extend nationwide.
More Nigerians should be encouraged to have health insurance to reduce the burden of treating facial injuries.
A pending bill in Colorado would disclose donor information to children and their parents and set limits on how many families can use a single individual’s egg or sperm.
When states reduce barriers for low-income children to get coverage, their mothers are more likely to be married and less likely to smoke.
Most states have taken advantage of the opportunity to expand access to Medicaid since 2014 through the Affordable Care Act. That’s helping reduce the number of uninsured people.
World AIDS Day on Dec. 1 this year comes at a time when a key step to removing financial barriers to PrEP access in the U.S. faces legal challenges.
The Affordable Care Act has allowed many preventive health services, including cancer screenings and vaccines, to be free of charge. But legal challenges may lead to costly repercussions for patients.
Ending the opioid epidemic requires addressing not only treatment gaps in addiction and overdose, but also inadequate pain management.
Two economists explain what insurers can and can’t do to factor vaccination status into their coverage and rates.
The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
Both are essential on a farm, but the costs are making it harder for young farmers to grow their businesses.
The US health system costs roughly twice as much as the Australian system per person. Despite this, the US has lower life expectancy than Australia.
Top contributors
-
Associate Professor of Public Health, The Ohio State University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Professor of Health Economics, The University of Melbourne
-
Research scientist of Health Policy and Economics, University of Southern California
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Research Scientist and Director of Research Training in Health Policy and Economics, University of Southern California
-
Assistant Professor of Health Policy and Management, UMass Amherst
-
Professor, Department of Health Policy, London School of Economics and Political Science
-
Senior Research Fellow and Lecturer of Gerontology, UMass Boston
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University